Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03748264 · ClinicalTrials.gov registry record · NA
User Preference/Validation Evaluation of the New Philips Respironics Positive Airway Pressure Application
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT03748264 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 62 participants.
The verdict
NCT03748264, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This pilot study is intended to evaluate the acceptance and performance of the DreamMapper application and the Therapist Assist educational tool in naïve patients with Obstructive Sleep Apnea who have been prescribed Positive Airway Pressure therapy. A total of approximately 60 naïve participants will be recruited.
Interventions
- OTHER Standard of Care
- DEVICE DreamMapper Application
- DEVICE DreamMapper Application with Therapist Assist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2013-10-21 |
| Est. Completion | 2014-05-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03748264
The ClinicalTrials.gov registry entry for NCT03748264 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Standard of Care is the first listed.
NCT03748264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03748264 about?
NCT03748264 is a clinical study titled "User Preference/Validation Evaluation of the New Philips Respironics Positive Airway Pressure Application". This pilot study is intended to evaluate the acceptance and performance of the DreamMapper application and the Therapist Assist educational tool in naïve patients with Obstructive Sleep Apnea who have been prescribed Positive Airway Pressure therapy. A total of approximately 60 naïve participants wi...
What is the current status of trial NCT03748264?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2013-10-21. Estimated completion is 2014-05-27.
What interventions are being tested in trial NCT03748264?
The interventions under investigation include: Standard of Care (OTHER), DreamMapper Application (DEVICE), DreamMapper Application with Therapist Assist (DEVICE).
Who is sponsoring clinical trial NCT03748264?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.